Karolina Piasecka‐Stryczynska

Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis

Xavier Montalbán, Douglas L. Arnold, Martin S. Weber et al. · New England Journal of Medicine · 2019 · 307 citations · Full text

Concentration of evobrutinib, a BTK inhibitor, in cerebrospinal fluid during treatment of patients with relapsing multiple sclerosis in a phase 2 study

Karolina Piasecka‐Stryczynska, Konrad Rejdak, Martin C. Dyroff et al. · Multiple Sclerosis and Related Disorders · 2021 · 17 citations

Neurobiology Of Disease, Neurological Disorder, Medicine +5

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine

Stewart J. Tepper, David W. Dodick, Michel Lantéri‐Minet et al. · JAMA Neurology · 2024 · 17 citations · Full text

“Positive Regulation of RNA Metabolic Process” Ontology Group Highly Regulated in Porcine Oocytes Matured<i> In Vitro</i>: A Microarray Approach

Piotr Celichowski, Mariusz J. Nawrocki, Marta Dyszkiewicz-Konwińska et al. · BioMed Research International · 2018 · 12 citations · Full text

Efficacy and safety results after &gt;3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study

Xavier Montalbán, Karolina Piasecka‐Stryczynska, Jens Kühle et al. · Multiple Sclerosis Journal · 2024 · 10 citations · Full text